ACADIA Pharmaceuticals presents at 35th J.P. Morgan Healthcare Conference

American Pharmacy News Reports | Feb 11, 2017
Information from ACADIA can be found on its website, at www.acadia-pharm.com.
Information from ACADIA can be found on its website, at www.acadia-pharm.com. | File photo
ACADIA Pharmaceuticals was chosen to present at the 35th Annual J.P. Morgan Healthcare Conference last month
ACADIA is a biopharmaceutical company that is investigating the commercialization of medications that are groundbreaking and that seek to discover how those medicines can treat central nervous system disorders. 
Information from ACADIA can be found on its website, at www.acadia-pharm.com, where the company posts recent news releases and more details about advances.
The conference was available via webcast, for those who were unable to attend. 
More News

Those with preexisting health conditions may experience a different immune response to the COVID-19 vaccination.

People CDC releases COVID-19 guidance for those with health conditions Jan 10, 2021

Novavax is the latest COVID-19 vaccine to enter Phase III clinical trials.

Innovation Fifth vaccine set to enter Phase III clinical trials Jan 3, 2021

Regulatory CENTENE: Completes Acquisition of PANTHERx Rare Pharmacy (PANTHERx) Dec 31, 2020

Industry NHA: Creates Partnership, Path for Accredited Immunization Training for Pharmacy Technicians Ahead of New Vaccines Dec 31, 2020

Industry TRANQUILMONEY: Releases PharmTracker for Independent Pharmacies, Small and Medium Pharmacy Chains Dec 26, 2020

Industry MITSUBISHI TANABE PHARMA AMERICA: Announces Initiation of Open-Label Extension Study of Oral Edaravone in ALS Dec 22, 2020

Trending

Those with preexisting health conditions may experience a different immune response to the COVID-19 vaccination.

CDC releases COVID-19 guidance for those with health conditions